GE HealthCare stock (US36266G1076): Nasdaq price steadies around mid-60 USD range after recent volatility

GE HealthCare shares on the Nasdaq Global Select Market traded around the mid-60 USD level in recent sessions, with the stock changing hands at about USD 62.64 on 05/30/2026 after moving between USD 62.19 and USD 63.04 during the day, according to Robinhood data as of 05/30/2026 and Google Finance as of late May 2026.

The United States-based medical technology group, which is listed under the ticker GEHC, thus remains well below its 52-week high of USD 89.77 but above the 52-week low near USD 58.75, based on Google Finance and Investing.com figures as of 05/30/2026.

The stock’s recent stabilization comes in the wake of a volatile year in which GE HealthCare delivered a roughly -11.6% share price change over the past 12 months, alongside an ex-dividend date on 04/02/2026, according to Investing.com and Google Finance as of 05/30/2026.

For US investors following the Nasdaq quote, GE HealthCare’s recent trading levels translate into a market capitalization of about USD 28.36 billion and a price-to-earnings ratio close to 14.9 as of 05/30/2026, according to Google Finance.

As of: 05/31/2026

By the editorial team - specialized in equity coverage.

GE HealthCare: core business model

GE HealthCare focuses on supplying hospitals and clinics worldwide with imaging, monitoring, and diagnostic solutions that help drive revenues primarily through equipment sales, software, and related service contracts across its core modalities.

Chart technicals and 52-week range

From a pure price-history perspective, GE HealthCare’s Nasdaq-listed shares have traded within a 52-week span between roughly USD 58.75 and USD 89.77, based on figures from Investing.com and Google Finance as of 05/30/2026.

With the stock recently quoted around USD 62.64 and a market capitalization near USD 28.36 billion, the current level sits closer to the lower end of that band, while the trailing price-to-earnings multiple of about 14.9 suggests the market is incorporating both recent earnings delivery and the broader US medtech sector backdrop, according to Google Finance as of 05/30/2026.

Conclusion

GE HealthCare’s US-listed stock is currently trading in the mid-60 USD area, positioning it in the lower portion of its 52-week range after a year of notable price swings.

The latest levels, combined with a market capitalization in the high-twenty-billion USD range and a trailing earnings multiple around the mid-teens, reflect how investors are balancing the company’s earnings profile with broader medtech sector conditions.

For market observers, the present chart setup and valuation metrics offer a snapshot of how the United States-based group is being priced relative to its recent history and the wider healthcare technology space.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.